SANTEN PHARMACEUTICAL CO earnings per share and revenue

4536/N earnings per share for the last quarter are 2.43 MXN whereas the estimation was 2.02 MXN which accounts for 20.49% surprise. Company revenue for the same period amounts to 9.27 B MXN despite the estimated figure of 8.87 B MXN. Estimated earnings per share for the next quarter are 1.92 MXN, and revenue is expected to reach 8.67 B MXN. Also watch annual changes over time to get a bigger picture of 4536/N earnings per share and revenue dynamics.